|
Re: IR
|
5
|
Resverlogix Corp.
|
Jan 18, 2023 01:30PM
|
|
Re: IR
|
4
|
Resverlogix Corp.
|
Jan 18, 2023 07:15AM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 10, 2023 01:49PM
|
|
Re: IR
|
5
|
Resverlogix Corp.
|
Jan 10, 2023 08:55AM
|
|
Re: Another quarter and not a peep
|
4
|
Resverlogix Corp.
|
Jan 04, 2023 01:38PM
|
|
Re: Another quarter and not a peep
|
5
|
Resverlogix Corp.
|
Jan 04, 2023 10:34AM
|
|
Re: Another quarter and not a peep
|
4
|
Resverlogix Corp.
|
Jan 04, 2023 10:19AM
|
|
Re: Another quarter and not a peep
|
5
|
Resverlogix Corp.
|
Jan 03, 2023 10:02PM
|
|
Re: China- 1 Million daily COVID cases
|
5
|
Resverlogix Corp.
|
Dec 28, 2022 02:31PM
|
|
Re: China- 1 Million daily COVID cases
|
5
|
Resverlogix Corp.
|
Dec 27, 2022 02:04PM
|
|
Re: China- 1 Million daily COVID cases
|
8
|
Resverlogix Corp.
|
Dec 27, 2022 08:18AM
|
|
Re: Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 20, 2022 08:16AM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
8
|
Resverlogix Corp.
|
Nov 20, 2022 08:29AM
|
|
Re: find it interesting that RVXCF.....
|
5
|
Resverlogix Corp.
|
Nov 09, 2022 02:51PM
|
|
Re: I followed up with Chris ..
|
6
|
Resverlogix Corp.
|
Nov 09, 2022 12:31PM
|
|
Re: SP 884+ Week Low.
|
2
|
Resverlogix Corp.
|
Oct 17, 2022 01:25PM
|
|
Re: SP 884+ Week Low.
|
3
|
Resverlogix Corp.
|
Oct 14, 2022 10:12AM
|
|
Re: Latest on COVID-19
|
5
|
Resverlogix Corp.
|
Sep 29, 2022 03:17PM
|
|
Re: Already posted by someone else??
|
3
|
Resverlogix Corp.
|
Sep 27, 2022 11:21AM
|
|
Re: No news
|
4
|
Resverlogix Corp.
|
Sep 17, 2022 11:08AM
|
